🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Primary Mediastinal B-cell Lymphoma (PMBCL)

SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma NCT06026319Phase 11 site📍 Boston Marcela V. Maus, M.D.,Ph.D. · Tests: CD79b-19 CAR T cells, Cyclophosphamide, Fludarabine Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma NCT06464861Phase 11 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: CD19-CAR-NK/T Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients NCT07473167Phase 1, Phase 21 site📍 Seoul TICAROS Co., Ltd. · Tests: TC011 Bio-CAR-T BS Study NCT05366569n/a1 site📍 Brescia Azienda Socio Sanitaria Territoriale degli Spedali Civili d… Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors NCT05934084NA40 sites📍 Ancona📍 Aviano📍 Bari Fondazione Italiana Linfomi - ETS · Tests: Lifestyles Implemented-Survivorship Care Plan (LS-SCP) CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies NCT04186520Phase 1, Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: 8/12-Day Production of Car-T Cells, 8/12-Day Production of Cryopreserved Car-T Cells, 12-Day Production of Car-T Cells Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) NCT06533579Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Vironexis Biotherapeutics Inc. · Tests: Dose Level 1, VNX-101, Dose Level 2, VNX-101, Dose Level 3, VNX-101, Dose Level 4, VNX-101 Pembro Plus CAR T-cell Therapy in R/R in PMBCL NCT05934448Phase 22 sites📍 Boston📍 New York Jennifer Crombie, MD · Tests: Pembrolizumab, Lymphodepletion Chemotherapy, Chimeric Antigen Receptor (CAR) Therapy Infusion, Leukapheresis Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) NCT07750886n/a1 site📍 Austin Natera, Inc. A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma NCT07788118Phase 1, Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: 7×19-THEMIS CAR-T cells Italian Observational Study on CAR-T Therapy for Lymphoma NCT06339255n/a1 site📍 Milan Paolo Corradini Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU NCT06116110n/a11 sites📍 Gilbert📍 Stanford📍 New Haven Miltenyi Biomedicine GmbH · Tests: Long-term Follow-Up Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients NCT04836507Phase 1, Phase 22 sites📍 Seoul📍 Seoul Curocell Inc. · Tests: CRC01, Fludarabine, Cyclophosphamide CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies NCT06208735Phase 17 sites📍 Calgary📍 Calgary📍 Vancouver British Columbia Cancer Agency · Tests: CLIC-2201 Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma NCT05826535Phase 1, Phase 235 sites📍 Irvine📍 Los Angeles📍 Los Angeles Lyell Immunopharma, Inc. · Tests: Rondecabtagene autoleucel (ronde-cel), Fludarabine, Cyclophosphamide A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma NCT06486051Phase 23 sites📍 Auckland📍 Christchurch📍 Newtown Malaghan Institute of Medical Research · Tests: Fludarabine, Cyclophosphamide, WZTL-002 CAR T-cells Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL NCT06500273Phase 285 sites📍 Gilbert📍 Hot Springs📍 Berkeley Allogene Therapeutics · Tests: cemacabtagene ansegedleucel, Fludarabine, Cyclophosphamide, Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™ DALY II USA/ MB-CART2019.1 for DLBCL NCT04792489Phase 232 sites📍 Birmingham📍 Gilbert📍 Phoenix Miltenyi Biomedicine GmbH · Tests: zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy